Cost-Effectiveness Decision Making and US Public Opinion
Author(s) -
Michael D. Botta,
Robert J. Blendon,
John M. Benson
Publication year - 2013
Publication title -
jama internal medicine
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 5.14
H-Index - 342
eISSN - 2168-6114
pISSN - 2168-6106
DOI - 10.1001/jamainternmed.2013.11332
Subject(s) - medicine , public opinion , clinical decision making , family medicine , law , politics , political science
HEALTH CARE REFORM Cost-Effectiveness Decision Making and US Public Opinion As nations seek to stem the tide of rising health care spending, many have turned to cost-effectiveness research (CER) as a way to reduce spending on low-value interventions. Agencies in the United Kingdom, Italy, Germany, and Australia judge the clinical benefits and costs of new treatments relative to the current standards of care and set explicit thresholds to justify paying for new treatments. In the United States, however, CER is the subject of ongoing political controversy, but little is known about Americans’ attitudes toward government use of CER in decision making. In this article, we present findings from a recently conducted nationwide public survey about CER. We report public opinion on government use of CER and on specific decisions driven by CER using vignettes derived from real-world international decisions.
Accelerating Research
Robert Robinson Avenue,
Oxford Science Park, Oxford
OX4 4GP, United Kingdom
Address
John Eccles HouseRobert Robinson Avenue,
Oxford Science Park, Oxford
OX4 4GP, United Kingdom